Skip to main content
Andrew Mihalache

Andrew Mihalache

Sep 10, 2026

3:45
Well, can you walk us through the major findings of this study?
3:49
Yeah, absolutely.
3:50
So for this study, we used the All of Us research program, which is this large, diverse cohort in the United States with over 300,000 participants, and using this data set, we were able to identify about 550 people who are diagnosed with Fuchs dystrophy, and then we matched them to about 5,500 controls who didn't have the condition.
4:11
And the idea behind this matching process was that we wanted to have two groups that were very similar and very comparable to each other.
4:18
So we made sure that these two groups were almost identical with respect to things like age, sex, race, ethnicity, uh, smoking and alcohol use, BMI, and other social determinants of health.
4:31
And then once we had these two comparable groups, we then asked ourselves, "Do patients with Fuchs have a greater prevalence of different cardiometabolic conditions compared to that similar control group?" And what we found was that people with Fuchs actually had a greater prevalence of some common conditions.
4:48
So for example, they were more likely to have diagnoses of type 2 diabetes, hypertension, high cholesterol levels, cerebrovascular disease, as well as obesity.
8:35
Um, do you all have a closing message about your study for our listeners?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.